Valmark Advisers Inc. Acquires 252 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Valmark Advisers Inc. boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,970 shares of the healthcare conglomerate’s stock after purchasing an additional 252 shares during the quarter. Valmark Advisers Inc.’s holdings in UnitedHealth Group were worth $3,549,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the stock. Auxano Advisors LLC increased its position in UnitedHealth Group by 17.4% in the second quarter. Auxano Advisors LLC now owns 1,093 shares of the healthcare conglomerate’s stock worth $557,000 after purchasing an additional 162 shares during the last quarter. Fairhaven Wealth Management LLC increased its position in UnitedHealth Group by 0.7% during the second quarter. Fairhaven Wealth Management LLC now owns 9,999 shares of the healthcare conglomerate’s stock valued at $5,092,000 after acquiring an additional 65 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. raised its stake in shares of UnitedHealth Group by 0.6% in the second quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 8,630 shares of the healthcare conglomerate’s stock valued at $4,395,000 after acquiring an additional 49 shares during the period. Summit Financial LLC raised its stake in shares of UnitedHealth Group by 38.6% in the second quarter. Summit Financial LLC now owns 24,544 shares of the healthcare conglomerate’s stock valued at $12,499,000 after acquiring an additional 6,837 shares during the period. Finally, Berry Wealth Group LP raised its stake in shares of UnitedHealth Group by 8.7% in the second quarter. Berry Wealth Group LP now owns 1,294 shares of the healthcare conglomerate’s stock valued at $659,000 after acquiring an additional 104 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on UNH. JPMorgan Chase & Co. increased their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Truist Financial raised their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Monday, August 19th. Royal Bank of Canada raised their price target on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Finally, Wells Fargo & Company raised their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $614.17.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded down $1.37 during midday trading on Friday, hitting $590.20. The company had a trading volume of 2,944,705 shares, compared to its average volume of 2,690,210. The stock has a market cap of $545.00 billion, a price-to-earnings ratio of 36.08, a PEG ratio of 1.64 and a beta of 0.59. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a fifty day simple moving average of $548.35 and a 200 day simple moving average of $512.42. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $593.26.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same period last year, the firm posted $6.14 EPS. UnitedHealth Group’s revenue was up 6.4% on a year-over-year basis. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.67 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.